Photo of Bexis

It’s been a tough two days for the drug and device industry.

Yesterday, Wyeth v. Levine.

Today, the Medical Device Safety Act of 2009, which is meant to reverse legislatively the Supreme Court’s pro-preemption decision in Riegel v. Medtronic.

Here’s a link to the House Committee on Energy and Commerce, which reports on the introduction of the MDSA in both the House and the Senate.

Drug & Device Resources

Bexis’ Book

FDA-regulated products now account for an estimated one-fifth of overall economic activity in the U.S. They have also been the focus of a litigation explosion. This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.
Learn More About This Book